机译:胸腔血管内主动脉修复(TEVAR)用于治疗主动脉疾病:与欧洲心脏病学(EAC)和欧洲心脏病学会(ESC)的欧洲心脏病学会(ESC)的职位陈述,与欧洲经皮心血管干预合作( EAPCI)
Department of Cardiovascular Surgery Hospital Hietzing Vienna Austria;
Interventional Cardiology Clínico San Carlos University Hospital Madrid Spain;
Department of Cardiovascular Surgery Zayed Military Hospital Abu Dhabi United Arab Emirates;
Department of Cardiothoracic Surgery University Hospital Birmingham NHS Foundation Trust;
Department of Cardiovascular Surgery University Hospital Berne Freiburgstrasse 18 3010 Berne;
Cardioangiological Center Bethanien Frankfurt Germany;
Hospital General Universitari Vall d'Hebron Barcelona Spain;
University Hospital S. Orsola Bologna Italy;
Department of Thoracic and Cardiovascular Surgery West German Heart Center Essen University;
Department of Interventional Radiology Rigshospitalet Copenhagen Denmark;
Heart Center Rostock University of Rostock Rostock Germany;
Department of Cardiology University of Bologna Bologna Italy;
Department of Radiology Rangueil Hospital Toulouse France;
Department of Vascular Surgery St. George's Vascular Institute St. george'S NHS Trust London;
Department of Cardiothoracic and Vascular Surgery Medical Center of Johannes Gutenberg University;
Department of Cardiology West-German Heart Center Essen University Duisburg-Essen Essen Germany;
Aneurysm; Aorta; Dissection; TEVAR;
机译:胸腔内血管主动脉修复(TEVAR)用于治疗主动脉疾病:欧洲心胸外科协会(EACTS)和欧洲心脏病学会(ESC)与欧洲经皮心血管介入协会合作发表的立场声明( EAPCI)。
机译:胸腔血管内主动脉修复(TEVAR)用于治疗主动脉疾病:与欧洲心脏病学(EAC)和欧洲心脏病学会(ESC)的欧洲心脏病学会(ESC)的职位陈述,与欧洲经皮心血管干预合作( EAPCI)
机译:经导管瓣膜植入术治疗主动脉瓣狭窄:欧洲心胸外科协会(EACTS)和欧洲心脏病学会(ESC)与欧洲经皮心血管介入协会(EAPCI)合作发表的立场声明。
机译:欧洲心律协会(EHRA)关于如何预防诊断和治疗心脏植入式电子设备感染的国际共识文件得到了心律协会(HRS)亚太心律协会(APHRS)和拉丁美洲心律的认可协会(LAHRS)国际心血管传染病学会(ISCVID)和欧洲临床微生物学和传染病学会(ESCMID)与欧洲心胸外科协会(EACTS)合作
机译:胸腔内血管主动脉修复术(TEVAR)用于治疗主动脉疾病:欧洲心胸外科协会(EACTS)和欧洲心脏病学会(ESC)与欧洲经皮心血管介入协会合作发表的立场声明( EAPCI)†